Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06930339 · ClinicalTrials.gov registry record
Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis
A clinical trial of Multiple Sclerosis, sponsored by Helius Medical.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06930339 is a study of Multiple Sclerosis that is active but no longer recruiting, run by Helius Medical. The registered enrollment target is 150 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06930339, a study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Helius Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The Registry will be designed to gather information over 3 years. This important health economic information will help to establish the value of the PoNS Device on key therapeutic outcomes. These outcomes will include: disease-associated injury risks (i.e., falls), onset of new comorbidities and/or worsening/improvement of existing medical condition(s) (other than gait deficit/impairment), need for new pharmacological/non-pharmacological intervention or increase/decrease of ongoing pharmacotherapy or other non-pharmacological intervention, increase/decrease of in patient/outpatient hospital and/or office visits or stays, side effects. By participation in the Registry, patients and physicians will be providing Helius with access to information about medical history, medical diagnoses, clinical symptom presentations, vocational information, medications, pharmacologic and non-pharmacologic prescriptions, hospitalization and healthcare visits, and any reported therapy's adverse events.
Conditions Studied
Interventions
- DEVICE Portable Neuromodulation Stimulator (PoNS)
Study Locations (1)
Pennsylvania
- Helius Medical - Newtown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06930339
The ClinicalTrials.gov registry entry for NCT06930339 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (74% lower). The listed sponsor is Helius Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Portable Neuromodulation Stimulator (PoNS) is the first listed.
NCT06930339 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06930339 about?
NCT06930339 is a clinical study titled "Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis". The Registry will be designed to gather information over 3 years. This important health economic information will help to establish the value of the PoNS Device on key therapeutic outcomes. These outcomes will include: disease-associated injury risks (i.e., falls), onset of new comorbidities and/or...
What is the current status of trial NCT06930339?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2023-05-01. Estimated completion is 2026-04-30.
What conditions does trial NCT06930339 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT06930339?
The interventions under investigation include: Portable Neuromodulation Stimulator (PoNS) (DEVICE).
Who is sponsoring clinical trial NCT06930339?
This trial is sponsored by Helius Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06930339 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.